GORE VIABIL Biliary Endoprosthesis: payments to doctors
Payments that named GORE VIABIL Biliary Endoprosthesis as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by W. L. Gore & Associates, Inc.?
W. L. Gore & Associates, Inc. reported the most payments naming GORE VIABIL Biliary Endoprosthesis. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $86K
- Providers
- 86
- Transactions
- 175
- Average per transaction
- $490
The per-transaction average — $490 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 86 providers the average total is $997, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| W. L. Gore & Associates, Inc. | $85,758 | 100.0% |
Other products from W. L. Gore & Associates, Inc.
The company that reported the most payments naming GORE VIABIL Biliary Endoprosthesis also reports against these.
- Product in Development$7,483,403
- GORE SYNECOR Biomaterial$2,466,798
- GORE CARDIOFORM Septal Occluder$2,396,448
- GORE-TEX Vascular Graft$2,165,883
- GORE ENFORM Preperitoneal Biomaterial$2,159,259
- GORE BIO-A Tissue Reinforcement$1,916,349
- GORE VIABAHN VBX Balloon Expandable Endo$1,899,832
- GORE TAG Thoracic Branch Endoprosthesis$1,661,042
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$1,391,415
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,150,387